Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells

Neurochemistry International

Volumn 106, Issue , 2017, Pages 62-73

  Zagoura, Dimitra ^a   Canovas Jorda, David ^a   Pistollato, Francesca ^a   Bremer Hoffmann, Susanne ^a   Bal Price, Anna ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Human induced pluripotent stem cells; Neuronal glial cultures; Nrf2 pathway; Rotenone

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; ROTENONE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR NRF2; TYROSINE 3 MONOOXYGENASE; VESICULAR GLUTAMATE TRANSPORTER 1; INSECTICIDE; NFE2L2 PROTEIN, HUMAN;

ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXIC CONCENTRATION; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; INDUCED PLURIPOTENT STEM CELL; MACROGLIA; NERVE CELL; NERVE CELL CULTURE; NEURAL STEM CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; COCULTURE; DRUG EFFECTS; FEMALE; METABOLISM; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; RAT;

ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INSECTICIDES; NEURONS; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; ROTENONE; SIGNAL TRANSDUCTION;

EID: 84994527381     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2016.09.004     Document Type: Article

References (58)

1. Avior, Y., Sagi, I., Benvenisty, N., Pluripotent stem cells in disease modelling and drug discovery. Nat. Rev. Mol. Cell Biol. 17:3 (2016 Mar), 170–182.
2. Bal-Price, A., Crofton, K.M., Leist, M., Allen, S., Arand, M., Buetler, T., Delrue, N., FitzGerald, R.E., Hartung, T., Heinonen, T., Hogberg, H., Bennekou, S.H., Lichtensteiger, W., Oggier, D., Paparella, M., Axelstad, M., Piersma, A., Rached, E., Schilter, B., Schmuck, G., Stoppini, L., Tongiorgi, E., Tiramani, M., Monnet-Tschudi, F., Wilks, M.F., Ylikomi, T., Fritsche, E., International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes. Arch. Toxicol. 89 (2015), 269–287.
3. Bal-Price, A., Crofton, K.M., Sachana, M., Shafer, T.J., Behl, M., Forsby, A., Hargreaves, A., Landesmann, B., Lein, P.J., Louisse, J., Monnet-Tschudi, F., Paini, A., Rolaki, A., Schrattenholz, A., Sunol, C., van Thriel, C., Whelan, M., Fritsche, E., Putative adverse outcome pathways relevant to neurotoxicity. Crit. Rev. Toxicol. 45 (2015), 83–91.
4. Bal-Price, A.K., Hogberg, H.T., Buzanska, L., Coecke, S., Relevance of in vitro neurotoxicity testing for regulatory requirements: challenges to be considered. Neurotoxicol Teratol. 32 (2010), 36–41.
5. Barker, A.J., Ullian, E.M., New roles for astrocytes in developing synaptic circuits. Commun. Integr. Biol. 1 (2008), 207–211.
6. Barrientos, A., Moraes, C.T., Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274 (1999), 16188–16197.
7. Bell, K.F., Al-Mubarak, B., Fowler, J.H., Baxter, P.S., Gupta, K., Tsujita, T., Chowdhry, S., Patani, R., Chandran, S., Horsburgh, K., Hayes, J.D., Hardingham, G.E., Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning. Proc. Natl. Acad. Sci. U. S. A., 108, 2011 E1–2;author reply E3–4.
8. Bryan, H.K., Olayanju, A., Goldring, C.E., Park, B.K., The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation. Biochem. Pharmacol. 85 (2013), 705–717.
9. Cabezas, R., El-Bacha, R.S., Gonzalez, J., Barreto, G.E., Mitochondrial functions in astrocytes: neuroprotective implications from oxidative damage by rotenone. Neurosci. Res. 74 (2012), 80–90.
10. Cannon, J.R., Tapias, V., Na, H.M., Honick, A.S., Drolet, R.E., Greenamyre, J.T., A highly reproducible rotenone model of Parkinson's disease. Neurobiol. Dis. 34 (2009), 279–290.
11. Desbordes, S.C., Studer, L., Adapting human pluripotent stem cells to high-throughput and high-content screening. Nat. Protoc. 8 (2013), 111–130.
12. Figley, C.R., Stroman, P.W., The role(s) of astrocytes and astrocyte activity in neurometabolism, neurovascular coupling, and the production of functional neuroimaging signals. Eur. J. Neurosci. 33 (2011), 577–588.
13. Fujita, K.A., Ostaszewski, M., Matsuoka, Y., Ghosh, S., Glaab, E., Trefois, C., Crespo, I., Perumal, T.M., Jurkowski, W., Antony, P.M., Diederich, N., Buttini, M., Kodama, A., Satagopam, V.P., Eifes, S., Del Sol, A., Schneider, R., Kitano, H., Balling, R., Integrating pathways of Parkinson's disease in a molecular interaction map. Mol. Neurobiol. 49 (2014), 88–102.
14. Gao, X.F., Wang, W., He, C., Rotenone inhibits delayed rectifier K+ current via a protein kinase A-dependent mechanism. Neuroreport 19 (2008), 1401–1405.
15. Gorrini, C., Harris, I.S., Mak, T.W., Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12 (2013), 931–947.
16. Harder, B., Jiang, T., Wu, T., Tao, S., de la Vega, M.R., Tian, W., Chapman, E., Zhang, D.D., Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention. Biochem. Soc. Trans. 43 (2015), 680–686.
17. Hartikainen, J.M., Tengstrom, M., Kosma, V.M., Kinnula, V.L., Mannermaa, A., Soini, Y., Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer. Cancer Res. 72 (2012), 5537–5546.
18. Harvey, C.J., Thimmulappa, R.K., Singh, A., Blake, D.J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A., Biswal, S., Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic. Biol. Med. 46 (2009), 443–453.
19. Hohler, B., Lange, B., Holzapfel, B., Goldenberg, A., Hanze, J., Sell, A., Testan, H., Moller, W., Kummer, W., Hypoxic upregulation of tyrosine hydroxylase gene expression is paralleled, but not induced, by increased generation of reactive oxygen species in PC12 cells. FEBS Lett. 457 (1999), 53–56.
20. Hou, Z., Zhang, J., Schwartz, M.P., Stewart, R., Page, C.D., Murphy, W.L., Thomson, J.A., A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res. Ther., 4(Suppl. 1), 2013, S12.
21. Hyslop, P.A., Zhang, Z., Pearson, D.V., Phebus, L.A., Measurement of striatal H2O2 by microdialysis following global forebrain ischemia and reperfusion in the rat: correlation with the cytotoxic potential of H2O2 in vitro. Brain Res. 671 (1995), 181–186.
22. Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., Yamamoto, M., Nabeshima, Y., An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236 (1997), 313–322.
23. Johnson, J.A., Johnson, D.A., Kraft, A.D., Calkins, M.J., Jakel, R.J., Vargas, M.R., Chen, P.C., The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N. Y. Acad. Sci. 1147 (2008), 61–69.
24. Kansanen, E., Kuosmanen, S.M., Leinonen, H., Levonen, A.L., The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 1 (2013), 45–49.
25. Kovac, S., Angelova, P.R., Holmstrom, K.M., Zhang, Y., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim. Biophys. Acta 1850 (2015), 794–801.
26. Krueger, W.H., Swanson, L.C., Tanasijevic, B., Rasmussen, T.P., Natural and artificial routes to pluripotency. Int. J. Dev. Biol. 54 (2010), 1545–1564.
27. Kumar, K.K., Aboud, A.A., Bowman, A.B., The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 33 (2012), 518–529.
28. Lee, J.M., Shih, A.Y., Murphy, T.H., Johnson, J.A., NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278 (2003), 37948–37956.
29. Li, L., Dong, H., Song, E., Xu, X., Liu, L., Song, Y., Nrf2/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K/AKT signaling. Chem. Biol. Interact. 209 (2014), 56–67.
30. Ma, Q., Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53 (2013), 401–426.
31. Nicholls, D.G., Budd, S.L., Mitochondria and neuronal survival. Physiol. Rev. 80 (2000), 315–360.
32. NRC, Toxicity Testing in the 21st Century: a Vision and a Strategy. 2007, National Academy Press, Washington (DC), 10.17226/11970 ISBN: 978-0-309-15173-3.
33. O'Brien, P.J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C.M., Slaughter, M.R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., Brain, P., Hougham, C., High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening. Arch. Toxicol. 80 (2006), 580–604.
34. Odawara, A., Saitoh, Y., Alhebshi, A.H., Gotoh, M., Suzuki, I., Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture. Biochem. Biophys. Res. Commun. 443 (2014), 1176–1181.
35. Patel, F., Pesticidal suicide: adult fatal rotenone poisoning. J. Forensic Leg. Med. 18 (2011), 340–342.
36. Pei, Y., Peng, J., Behl, M., Sipes, N.S., Shockley, K.R., Rao, M.S., Tice, R.R., Zeng, X., Comparative neurotoxicity screening in human iPSC-derived neural stem cells, neurons and astrocytes. Brain Res. 1638 (2016), 57–73.
37. Peng, J., Liu, Q., Rao, M.S., Zeng, X., Using human pluripotent stem cell-derived dopaminergic neurons to evaluate candidate Parkinson's disease therapeutic agents in MPP+ and rotenone models. J. Biomol. Screen 18 (2013), 522–533.
38. Pistollato, F., Bremer-Hoffmann, S., Healy, L., Young, L., Stacey, G., Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin. Drug Metab. Toxicol. 8 (2012), 239–257.
39. Pistollato, F., Louisse, J., Scelfo, B., Mennecozzi, M., Accordi, B., Basso, G., Gaspar, J.A., Zagoura, D., Barilari, M., Palosaari, T., Sachinidis, A., Bremer-Hoffmann, S., Development of a pluripotent stem cell derived neuronal model to identify chemically induced pathway perturbations in relation to neurotoxicity: effects of CREB pathway inhibition. Toxicol. Appl. Pharmacol. 280 (2014), 378–388.
40. Radad, K., Gille, G., Rausch, W.D., Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture. Toxicol. In Vitro 22 (2008), 68–74.
41. Ramsey, C.P., Glass, C.A., Montgomery, M.B., Lindl, K.A., Ritson, G.P., Chia, L.A., Hamilton, R.L., Chu, C.T., Jordan-Sciutto, K.L., Expression of Nrf2 in neurodegenerative diseases. J. Neuropathol. Exp. Neurol. 66 (2007), 75–85.
42. Robinton, D.A., Daley, G.Q., The promise of induced pluripotent stem cells in research and therapy. Nature 481 (2012), 295–305.
43. Santello, M., Volterra, A., Synaptic modulation by astrocytes via Ca2+-dependent glutamate release. Neuroscience 158 (2009), 253–259.
44. Satoh, T., Harada, N., Hosoya, T., Tohyama, K., Yamamoto, M., Itoh, K., Keap1/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice. Biochem. Biophys. Res. Commun. 380 (2009), 298–302.
45. Sherer, T.B., Kim, J.H., Betarbet, R., Greenamyre, J.T., Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation. Exp. Neurol. 179 (2003), 9–16.
46. Shih, A.Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., Murphy, T.H., Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J. Biol. Chem. 280 (2005), 22925–22936.
47. Steele, M.L., Fuller, S., Patel, M., Kersaitis, C., Ooi, L., Munch, G., Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol. 1 (2013), 441–445.
48. Sun, Z., Zhang, S., Chan, J.Y., Zhang, D.D., Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell Biol. 27 (2007), 6334–6349.
49. Swarnkar, S., Singh, S., Goswami, P., Mathur, R., Patro, I.K., Nath, C., Astrocyte activation: a key step in rotenone induced cytotoxicity and DNA damage. Neurochem. Res. 37 (2012), 2178–2189.
50. Tamura, A., Yamada, N., Yaguchi, Y., Machida, Y., Mori, I., Osanai, M., Both neurons and astrocytes exhibited tetrodotoxin-resistant metabotropic glutamate receptor-dependent spontaneous slow Ca2+ oscillations in striatum. PLoS One, 9, 2014, e85351.
51. Tanner, C.M., Kamel, F., Ross, G.W., Hoppin, J.A., Goldman, S.M., Korell, M., Marras, C., Bhudhikanok, G.S., Kasten, M., Chade, A.R., Comyns, K., Richards, M.B., Meng, C., Priestley, B., Fernandez, H.H., Cambi, F., Umbach, D.M., Blair, A., Sandler, D.P., Langston, J.W., Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 119 (2011), 866–872.
52. Testa, C.M., Sherer, T.B., Greenamyre, J.T., Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res. Mol. Brain Res. 134 (2005), 109–118.
53. Tollefsen, K.E., Scholz, S., Cronin, M.T., Edwards, S.W., de Knecht, J., Crofton, K., Garcia-Reyero, N., Hartung, T., Worth, A., Patlewicz, G., Applying adverse outcome pathways (AOPs) to support integrated Approaches to testing and assessment (IATA). Regul. Toxicol. Pharmacol. 70 (2014), 629–640.
54. Tufekci, K.U., Civi Bayin, E., Genc, S., Genc, K., The Nrf2/are pathway: a promising target to counteract mitochondrial dysfunction in Parkinson's disease. Park. Dis., 2011, 2011, 314082.
55. Vassallo, A., Chiappalone, M., De Camargos Lopes, R., Scelfo, B., Novellino, A., Defranchi, E., Palosaari, T., Weisschu, T., Ramirez, T., Martinoia, S., Johnstone, A.F., Mack, C.M., Landsiedel, R., Whelan, M., Bal-Price, A., Shafer, T.J., A multi-laboratory evaluation of microelectrode array-based measurements of neural network activity for acute neurotoxicity testing. Neurotoxicology, 2016.
56. Wheeler, H.E., Wing, C., Delaney, S.M., Komatsu, M., Dolan, M.E., Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells. PLoS One, 10, 2015, e0118020.
57. Yap, M.S., Nathan, K.R., Yeo, Y., Lim, L.W., Poh, C.L., Richards, M., Lim, W.L., Othman, I., Heng, B.C., Neural differentiation of human pluripotent stem cells for nontherapeutic applications: toxicology, pharmacology, and in vitro disease modeling. Stem Cells Int., 2015, 105172.
58. Zhou, Y., Duan, S., Zhou, Y., Yu, S., Wu, J., Wu, X., Zhao, J., Zhao, Y., Sulfiredoxin-1 attenuates oxidative stress via Nrf2/ARE pathway and 2-Cys Prdxs after oxygen-glucose deprivation in astrocytes. J. Mol. Neurosci. 55 (2015), 941–950.